TB
AI-enabled technology for cell biology research and biopharma development.
About
Tolemy Bio is a biotech startup developing Orbit, an AI-native platform designed to help researchers better understand, interpret, and optimize living cells for modern therapies and drug development. The platform aims to address the fragmentation and manual nature of current experimental workflows by connecting existing lab tools and data sources, incorporating virtual cell models, and utilizing AI research agents for analysis and decision-making. Their long-term goal is to build a virtual-cell platform that enables more precise and data-driven approaches to cell biology research and biopharma development.
Tags
Total Employees
4
Current headcount
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Tolemy Bio do?
Tolemy Bio is a biotech startup developing Orbit, an AI-native platform designed to help researchers better understand, interpret, and optimize living cells for modern therapies and drug development. The platform aims to address the fragmentation and manual nature of current experimental workflows by connecting existing lab tools and data sources, incorporating virtual cell models, and utilizing AI research agents for analysis and decision-making. Their long-term goal is to build a virtual-cell…
How much funding has Tolemy Bio raised?
Tolemy Bio has raised a total of $11M in funding. The most recent round on record is Pre-Seed.
Where is Tolemy Bio headquartered?
Tolemy Bio is headquartered in Cambridge, England, United Kingdom.
When was Tolemy Bio founded?
Tolemy Bio was founded in 2022.
What industry does Tolemy Bio operate in?
Tolemy Bio operates in Biotechnology, Artificial Intelligence, Drug Discovery, Life Sciences, Biotech, AI-Driven Protein Design.
How many employees does Tolemy Bio have?
Tolemy Bio has approximately 4 people on record.
Similar Startups